Video
Jessica Steen, OD, FAAO, shares key takeaways from her AOA 2022 presentation, "Problem Solving in Glaucoma Management."
Video
Jessica Steen, OD, FAAO, shares why she views the development of OCT-angiography as her personal favorite technological advancement in eyecare.
Article
FDA review pathway looks to balance innovation with data review
Article
Use of intravitreal biologics, steroids, and improvements to vitreoretinal surgical techniques have improved the prognosis of vitreoretinal conditions. Ocular hypertension, which may lead to secondary open-angle glaucoma, is a common complication both short- and long-term following intravitreal injection of anti-VEGF or steroid agent and PPV—especially when silicone oil is used as a tamponade agent. Understanding these potential risks is key to early detection, diagnosis, and management following vitreoretinal procedures.